Litcius/Paper detail

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer

Elizabeth A. Bowling, Jarey H. Wang, Fade Gong, William Wu, Nicholas J. Neill, Ik Sun Kim, Siddhartha Tyagi, Mayra Orellana, Sarah J. Kurley, Rocío Domínguez-Vidaña, Hsiang-Ching Chung, Tiffany Hsu, Julien Dubrulle, Alexander B. Saltzman, Heyuan Li, Jitendra K. Meena, Gino Martin Canlas, Srinivas Chamakuri, Swarnima Singh, Lukas M. Simon, Calla M. Olson, Lacey E. Dobrolecki, Michael T. Lewis, Bing Zhang, Ido Golding, Jeffrey M. Rosen, Damian W. Young, Anna Malovannaya, Fabio Stossi, George Miles, Matthew J. Ellis, Lihua Yu, Silvia Buonamici, Charles Y. Lin, Kristen L. Karlin, Xiang H.-F. Zhang, Thomas F. Westbrook

2021Cell212 citationsDOIOpen Access PDF

Topics & Concepts

BiologySpliceosomeRNA splicingImmune systemCancer researchRNARNA silencingAlternative splicingCancerInnate immune systemBreast cancerTriple-negative breast cancerRNA interferenceImmunologyMessenger RNAGeneticsGeneRNA Research and Splicinginterferon and immune responsesRNA regulation and disease
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer | Litcius